Chief Executive Officer

We’re searching for a CEO to lead our next phase — advancing our product roadmap, building strong partnerships, and growing our impact in healthcare. Role Overview Clear Dynamic is a clinical-stage medical device company headquartered in Halifax, Nova Scotia, with a team of 26 employees. As the company advances its clinical development program, we are seeking a seasoned CEO to lead the organization through its next stage of growth. The CEO will provide strategic and operational leadership across clinical, regulatory, and commercial functions. Key responsibilities include overseeing clinical trials, driving FDA regulatory strategy, and preparing for early commercialization — all while ensuring these efforts are aligned with long-term value creation and potential exit pathways. The current CEO, who also serves as Chief Scientific Officer (CSO), will transition fully into the CSO role, ensuring continuity of scientific vision and innovation. The incoming CEO will work in close partnership with the CSO, the Board, and the leadership team to integrate clinical, technical, and operational priorities into a cohesive, value-driven roadmap. The ideal candidate will bring deep expertise in FDA regulatory pathways, strong medical device marketing acumen, and a proven track record of leading early-stage companies through critical inflection points. The CEO will play a pivotal role in aligning operational execution with funding milestones, financial strategy, and corporate value creation — including advancing clinical trials, regulatory filings, go-to-market planning, and the securing of strategic and non-dilutive funding. This position offers location flexibility within the U.S. Northeast, with a compensation package commensurate with experience. Key Responsibilities Strategic Leadership Define and communicate a clear vision and strategic roadmap for the company. Work closely with the CSO to translate the company’s scientific and clinical progress into compelling narratives for investors, partners, and grant agencies. Align R&D and clinical strategies with financial planning to ensure resources are allocated effectively for trial execution and regulatory milestones. Co-lead scientific and clinical presentations to potential funders, strategic partners, and regulatory stakeholders. Regulatory & Commercial Readiness Define early commercial strategy elements, including reimbursement pathways, pricing frameworks, and market access considerations in alignment with clinical and regulatory milestones. Lead the development and execution of FDA regulatory strategies (IDE, 510(k), PMA, or De De Novo). Shape the go-to-market strategy including segmentation, positioning, KOL engagement, and pricing. Identify and pursue strategic partnerships with commercial, manufacturing, or distribution entities that can bring capital, technical capabilities, or market access. Evaluate potential co-development, early commercialization agreements and exit pathways (e.g., M&A). Fundraising & Investor Relations Lead fundraising efforts across a diverse spectrum, including strategic investors, family offices, grants, institutional capital, and non-dilutive funding sources. Develop and deliver investor-facing materials, including pitch decks, data packages, and clinical/regulatory updates. Manage due diligence processes and maintain strong relationships with current and prospective funders. Communicate a clear, credible, and differentiated value proposition based on clinical evidence, unmet need, and commercial potential. Maintain transparent and consistent communication with investors and the Board. Drive valuation growth through strategic milestones. Team Leadership & Operational Efficiency Establish the leadership structure and operational cadence necessary to support clinical advancement, regulatory execution, and capital strategy. Ensure systems are in place for financial oversight, performance monitoring, and strategic alignment across functions. Maintain a culture of accountability, transparency, and capital discipline, with a focus on long-term value creation. Oversee product development, manufacturing partnerships, and quality systems. Ensure financial discipline, risk management, and scalability. Qualifications Required: 10+ years of leadership in the medical device industry, preferably with startup or growth-stage companies. Direct experience leading FDA regulatory processes (510(k), PMA, De Novo) for Class II or III devices. Proven track record in commercial strategy and marketing for medical devices, especially embolic, neurovascular, or interventional products. Demonstrated ability to raise capital and work with investors and boards. Preferred: Previous experience as CEO, President, or GM of a medical device company. Experience in embolic, neurovascular, cardiovascular, or interventional oncology fields. Advanced degree in business, science, or engineering (e.g., MBA, MD, PhD). This is a unique opportunity to lead a passionate team and bring transformative technology to the patients and providers who need it most. Reach out directly at careers@cleardynamic.com #J-18808-Ljbffr